Recombinant Mouse Neutralizing Antibody (8F5) is capable of binding to HRV2 VP2, expressed in Chinese Hamster Ovary cells (CHO).
Figure 1 HeLa-FcRII cells were grown on coverslips, incubated with 8F5 (40 μg/ml) or with 3B10 (15 μg/ml) at 4°C for 1 h, washed, fixed, and stained with Alexa 488-conjugated goat anti-mouse antibodies. Subsequently, cells were incubated with 2.4G2 followed by Alexa 568-conjugated goat anti-rat antibody. Nuclei were stained with Hoechst dye. Note the absence of Alexa 488 staining in cells that do not express FcRII (arrows). Bar, 20 μm.
Baravalle, G., Brabec, M., Snyers, L., Blaas, D., & Fuchs, R. (2004). Human rhinovirus type 2-antibody complexes enter and infect cells via Fc-γ receptor IIB1. Journal of virology, 78(6), 2729-2737.
Figure 2 Parental HeLa cells or HeLa-FcRII cells were incubated with 8F5 (40 μg/ml) or 3B10 (15 μg/ml) at 4°C for 1 h, washed, fixed, and stained with Alexa 488-conjugated goat anti-mouse antibodies followed by incubation with 2.4G2 and Alexa 568-conjugated goat anti-rat antibodies. Cells were analyzed by flow cytometry (for details, see Materials and Methods). One typical experiment out of three is shown. Note that only those cells that express FcRII bound the MAbs.
Baravalle, G., Brabec, M., Snyers, L., Blaas, D., & Fuchs, R. (2004). Human rhinovirus type 2-antibody complexes enter and infect cells via Fc-γ receptor IIB1. Journal of virology, 78(6), 2729-2737.
Figure 3 MAbs 8F5 and 3B10 are internalized into HeLa-FcRII cells.
Cells were incubated at 34°C with 8F5 (40 μg/ml), 3B10 (15 μg/ml), or the control antibody 5H5 subtype IgG3 (40 μg/ml) for 60 min (8F5, 5H5) or for 20 min (3B10). Cells were washed, permeabilized (A) or nonpermeabilized (B), and processed for immunofluorescence microscopy as in Fig. Fig.2.2. Note the perinuclear colocalization of MAbs and FcRII in permeabilized cells, indicative of localization in late endosomes (arrowheads), and the absence of any antibody uptake in FcRII-negative cells (right-hand panels, arrows). The control antibody 5H5 was not internalized by HeLa-FcRII cells. Bar, 20 μm.
Baravalle, G., Brabec, M., Snyers, L., Blaas, D., & Fuchs, R. (2004). Human rhinovirus type 2-antibody complexes enter and infect cells via Fc-γ receptor IIB1. Journal of virology, 78(6), 2729-2737.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PSBL-201 | Recombinant Mouse Anti-HRV2 VP2 Antibody scFv Fragment (8F5) | WB, ELISA, IF, FuncS | scFv |
FAMAB-0295-YC-S(P) | Recombinant Chicken Anti-VP2 Antibody scFv Fragment (CRAb 88) | ELISA, IP, WB | Chicken scFv |
FAMAB-0140-CN-S(P) | Recombinant Human Anti-VP2 Antibody scFv Fragment (860-55D) | WB, ELISA, FC | Human scFv |
HPAB-0133-WJ-S(P) | Recombinant Mouse Anti-VP2 Antibody scFv Fragment (# 4) | ELISA | Mouse scFv |
HPAB-0134-WJ-S(P) | Recombinant Mouse Anti-VP2 Antibody scFv Fragment (# 6) | ELISA | Mouse scFv |
There are currently no Customer reviews or questions for PABL-201. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.